Northrim BanCorp, Inc. (NRIM)

Northrim BanCorp presents a compelling case for a medium-term swing trade backed by solid fundamentals. The stock has executed a remarkable recovery over the last nine years, surging 233% cumulatively as it shed its pandemic-era baggage to return to profitability. Currently trading at a forward P/E of roughly 10x with a 21% return on equity, the valuation appears compressed relative to its earnings power, offering a margin of safety for patient buyers. The short-term outlook is constructive but cautious. Price action shows the stock testing key resistance levels near $28-$30, a zone where institutional sellers often step in. While the statistical forecast model offers only a modest upward lean, the options market is telling a different story: traders are buying calls at the $30 strike while ignoring the downside, creating a bullish skew that could fuel a breakout if volume picks up. However, the lack of significant put volume suggests this rally lacks a broad-based hedging floor, making a sharp reversal possible if momentum stalls. For the long-term investor, the thesis is strong. The company has demonstrated resilience, with revenue growing 6% year-over-year and earnings ticking up. The balance sheet remains healthy, and the payout ratio is conservative at roughly 22%, leaving ample room for future dividend growth. While the stock is not yet a 'compounder' in the vein of the absolute best banks, it is a high-quality regional player trading at a discount that warrants a 4-star rating. The primary risk is the slow pace of execution; the stock has been volatile, and the path to $30 may require patience.